EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial

Mark Rishniw

Advances in Small Animal Medicine and Surgery · 2017-04 · 30 (4) · 1-3

DOI: 10.1016/j.asams.2017.03.008 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Advances in Small Animal Medicine and Surgery, 2017-04. Verfasst von Mark Rishniw. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rishniw, M. (2017). Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial. Advances in Small Animal Medicine and Surgery, 30(4), 1-3. https://doi.org/10.1016/j.asams.2017.03.008

Vancouver

Rishniw M. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial. Advances in Small Animal Medicine and Surgery. 2017;30(4):1-3. doi:10.1016/j.asams.2017.03.008

BibTeX
@article{Rishniw2017,
  author = {Rishniw, Mark},
  title = {Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial},
  journal = {Advances in Small Animal Medicine and Surgery},
  year = {2017},
  volume = {30},
  number = {4},
  pages = {1--3},
  doi = {10.1016/j.asams.2017.03.008}
}
Kostenlos starten →